Sanofi (NASDAQ:SNY) Issues Earnings Results, Meets Estimates

Sanofi (NASDAQ:SNY) released its earnings results on Thursday. The company reported $0.70 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.70, Zacks reports. Sanofi had a return on equity of 27.45% and a net margin of 9.96%.

Sanofi Stock Up 3.5 %

Shares of NASDAQ:SNY traded up $1.85 during midday trading on Thursday, reaching $54.00. The company had a trading volume of 2,795,495 shares, compared to its average volume of 2,564,498. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average price is $48.99 and its 200 day moving average price is $52.22. The stock has a market cap of $137.04 billion, a PE ratio of 27.56, a P/E/G ratio of 1.19 and a beta of 0.57. Sanofi has a 1-year low of $45.22 and a 1-year high of $58.97.

Analyst Ratings Changes

Separately, StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.